Navigation Links
New Video on Plasma Donation Available
Date:1/28/2011

ANNAPOLIS, Md., Jan. 28, 2011 /PRNewswire/ -- Anyone curious about what to expect as a plasma donor and how plasma contributes to lifesaving medicines can now learn about the process thanks to a new DVD from the Plasma Protein Therapeutics Association (PPTA). "Becoming a Plasma Donor," details the safety and eligibility steps required to become a committed plasma donor at one of the 400-plus U.S. Food and Drug Administration-licensed and International Quality Plasma Program-certified plasma collection centers in the United States. The 10 minute video illustrates how critically important plasma donors are to the production of safe and effective therapies that help individuals coping with rare, chronic, life-threatening diseases.

PPTA's DVD guides viewers step-by-step through the process that a new plasma donor experiences when applying to donate plasma, from the completion and review of the health history questionnaire to the physical examination to the donation process itself.  

"I'm pleased to announce this new resource, which gives people who are interested in donating plasma important information on the plasma donation process and shows viewers what they can expect," said PPTA President and CEO Jan M. Bult.

Plasma protein therapies are used to treat life-threatening, rare, chronic diseases and disorders such as hemophilia, primary immunodeficiencies, alpha-1 antitrypsin deficiency and neurological and autoimmune disorders. In addition, plasma protein therapies are used to treat other serious medical conditions such as shock, trauma, and burns.

"A major goal of PPTA is to help promote the understanding of and access to safe and effective plasma protein therapeutics for all patients in the world," said Bult. "This DVD is an educational tool that showcases the numerous safety measures in place to protect the health of the donor and the patients who rely on therapies made from plasma."

The International Quality Plasma Program (IQPP) is a voluntary industry certification that complements the regulatory requirements of U.S. and international government authorities that govern the collection of source plasma used to manufacture therapies. The achievement of certification illustrates the industry's ongoing commitment to quality and safety.

To view the DVD online, please go to: http://www.pptaglobal.org/news/videos/plasma-donation.aspx. To obtain a copy of the new DVD, please contact Diana Krueger at dkrueger@pptaglobal.org or (443) 433-1107. For more information on the video or the plasma protein therapeutics industry, please contact Kara Flynn at (443) 458-4669 or Kym H. Kilbourne at (443) 458-4682.

The Plasma Protein Therapeutics Association (PPTA) represents the world's leading manufacturers of plasma-derived and recombinant biological therapies, collectively known as plasma protein therapies. These critical therapies are infused or injected by more than 1 million people worldwide to treat a variety of rare, life threatening diseases and serious medical conditions. PPTA members produce in excess of 80 percent of the plasma protein therapies used in the United States today and more than 60 percent worldwide. The manufacturer membership of PPTA in the United States currently includes Baxter, Biotest, Cangene, CSL Behring, Grifols, and Talecris. PPTA is a global trade association that administers international, voluntary standards programs to help ensure the highest quality and safety of plasma protein therapies and the plasma collected to manufacture them. Additionally, PPTA works in partnership with the patient community and consumer advocates to help ensure continued access to lifesaving plasma protein therapies.


'/>"/>
SOURCE Plasma Protein Therapeutics Association (PPTA)
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
2. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
3. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
4. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
5. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
6. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
7. Video: Keppra XR(TM) Approved in the U.S.
8. Video: Fortune 1000 Executives: New President Must Fix Education Gap
9. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMeds Peer-Reviewed Video Journal JoVE
10. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
11. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... ACEA Biosciences, Inc. announced today ... clinical trials for AC0010 at the World Conference on Lung Cancer 2016, taking place ... on the phase I/II clinical trials for AC0010 in patients with advanced non-small cell ...
(Date:12/2/2016)... ... December 01, 2016 , ... PhUSE will build on the ... US Single Day Events (SDE) to organize a multiple-day US conference. The first ... Topics of the pharmaceutical and life sciences industry will cover industry standards, data ...
(Date:12/2/2016)... ... 2016 , ... Orthogonal, a Chicago-based medical device software company, ... 510(k) clearance for their flagship medical device, SimplECG. , With this FDA approval, ... rely on cloth-based nanosensors. While other companies have attempted to focus on wearable ...
(Date:12/2/2016)... YORK , Dec. 1, 2016   SurePure, ... photopurification, announced today that the Company has concluded an ... the right for a 90-day period to acquire units ... value of approximately USD 3.7 million.  ... agreement with Tamarack under which Tamarack will seek regulatory ...
Breaking Biology Technology:
(Date:11/29/2016)... 29, 2016   Neurotechnology , a ... recognition technologies, today released FingerCell 3.0, a ... solutions that run on low-power, low-memory microcontrollers. ... less than 128KB of memory, enabling it ... have limited on-board resources, such as: mobile ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... Medical LiveWire Healthcare and Life Sciences Awards as ... caps off an unprecedented year of recognition and growth ... for over 15 years. iMedNet ...
(Date:11/16/2016)... , Nov. 16, 2016 Sensory Inc ... and security for consumer electronics, and VeriTran ... and retail industry, today announced a global partnership ... way to authenticate users of mobile banking and ... TrulySecure™ software which requires no specialized biometric ...
Breaking Biology News(10 mins):